Thierry Billoué

Debiopharm International SA operates as a biopharmaceutical development company with focus on biologics and drug evaluation, licensing and development. It formulates and develops products for the treatment of cancer, endometriosis, uterine fibroids and hepatitis. The company was founded in 1979 and is headquartered in Lausanne, Switzerland.

SPI-bio SA develops and markets immunological reagents and kits for xenobiotics and endogenous molecules. It assists clients from screening of candidate drugs to manufacturing and distribution of clinical supplies. The company was founded in 1991 and is headquartered in Massy, France.

Mutabilis SA specializes in the discovery and development of anti-infective drugs. It focuses on novel therapeutic approaches for controlling severe and nosocomial infections. The firm offers antibacterial, vaccines, anti-infective agents, gram-positive & negative ant virulence lead series, specific antigens, and screening technologies for antibacterial and virulence targets. The company was founded in 2001 by Xavier Nassif and is headquartered in Romainville, France.

Johnson & Johnson Pharmaceutical Research & Development LLC provides research and development support services. It offers drug discovery and drug development in a variety of therapeutic areas, including CNS, Internal Medicine and Oncology, to address unmet medical needs worldwide. The company is headquartered in Raritan, NJ.

CM-CIC Innovation SASU is a Venture Capital firm, a subsidiary of CM CIC Investissement SA founded in 1988. CM-CIC Innovation SASU is headquartered in Paris, France.

Coldway SA manufactures and sells sanitary storage solutions to the healthcare, logistics, and food industries. Its products include stand-alone refrigerated container, refrigerated roll, and other related equipment such as ice and insulated boxes. The company was founded by Laurent Rigaud and Francis Kindbeiter in 2001 and is headquartered in Pia, France.

Confederation Nationale Crédit Mutuel SA engages in the provision of banking services. It offers the following business activities: Retail banking, Insurance, Asset Management and Private Banking, Investment bank and,Technology services. The company was founded by Frédéric-Guillaume Raiffeisen in 1847 and is headquartered in Paris, France.

EndoControl SAS designs, develops and markets robotics solutions for laparoscopic surgeries. It markets a range of products including, ViKY EP, a laparoscopic motorized endoscope holder; ViKY UP, a motorized uterus positioner and; JAiMY, the first 5mm motorized articulated laparoscopic instrument with iD-Intelligent Dexterity. The company was founded by Clement Vidal and Patrick Henri in 2006 and is headquartered in Grenoble, France.

SILIOS Technologies SA designs and manufactures micro-optics for a wide range of applications from UV to IR. Its products include CS filters for spectrometry, CS filters for multispectral imaging, CMS cameras, instruments, and laser beam shaping. The company was founded by Michel-Jean Dupre, Laurent Roux, and Stéphane Tisserand on August 27, 2001 and is headquartered in Peynier, France.

ImmunID SAS researches and develops diagnostic tools for monitoring immune cell repertoire. It specializes in combinatorial repertoire analysis. The firm provides tests which translate the complexity of the immune system into clinically meaningful data. The company was founded by Nicolas Pasqual and Sébastien Weisbuch on March 25, 2005 and is headquartered in Grenoble, France.

Sanofi-Aventis France engages in wholesale of pharmaceutical products. The company is headquartered in Gentilly, France.

Krono-Safe SA provides software solutions for the development of embedded systems. It offers embedded operating systems for critical industrial applications such as automotive, aerospace, rail, energy and medical. The company was founded by Damien Chabrol and Didier Roux in 2011 and is headquartered in Orsay, France.

Tissium SA engages in the development and commercialization of biodegradable sealants and adhesives for invasive surgery. It offers biomimetic wound closure solutions. The company was founded by Bernard J. Gilly, Robert S. Langer, Christophe Bancel, Jeff Karp, Jacques Marescaux, Maria Pereira, and Patrick Houvet in 2013 and is headquartered in Paris, France.

Synthelis SAS manufactures membrane proteins. It specializes in the production, purification, and characterization of custom membrane proteins. The firm's services Membrane Protein (MP) expression, proteoliposomes, MP in detergents, feasibility study, and quality controls. Synthelis' technology enables the embedding of membrane proteins in liposomes directly during the translation step, allowing the production of active ready-to-use proteoliposomes. The company was founded by Bruno Tillier and Jean-Luc Lenormand in January 2011 and is headquartered in La Tronche, France.

Bertin Pharma SAS provides research and development solutions and supplies bioreagent tools for the pharmaceutical industry. The company is headquartered in France.

GIE Pharm'image operates as a platform for pharmacology. The private company is based in Dijon, France.

Sc Pcg provides fund management services.

Sci Nag engages in the rental of land and other real estate properties. The private company is based in Paris, France.

Oncodesign USA, Inc. manufactures pharmaceutical products. The private company is based in Cambridge.

Société Financière Aquitaine De Participation is an investment holding private company based in Paris, France. The French company functions as an investment holding company.

PK/PDesign SASU engages in the research and development of biotechnology. The private company is based in Dijon, France.

Oncodesign Services SA is a contract research organization that specializes in drug discovery and preclinical services. The company is based in Dijon, France, and has subsidiaries in Canada. The French company contributes to the development of innovative therapies in oncology, inflammation, and infectious diseases through integrated capabilities in medicinal chemistry, DMPK, pharmaco-imaging, bioanalysis, and in vivo/in vitro pharmacology. The company was founded in 1995 by Philippe Genne, and Fabrice Viviani has been the CEO of the company since December 01, 2022.